The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 08, 2006
Filed:
Feb. 26, 2002
Toshihiro Nishimura, Nagano, JP;
Nobuhiko Fushimi, Nagano, JP;
Hideki Fujikura, Nagano, JP;
Kenji Katsuno, Nagano, JP;
Yoshimitsu Komatsu, Nagano, JP;
Masayuki Isaji, Nagano, JP;
Toshihiro Nishimura, Nagano, JP;
Nobuhiko Fushimi, Nagano, JP;
Hideki Fujikura, Nagano, JP;
Kenji Katsuno, Nagano, JP;
Yoshimitsu Komatsu, Nagano, JP;
Masayuki Isaji, Nagano, JP;
Kissei Pharmaceutical Co., Ltd., Nagano, JP;
Abstract
The present invention provides glucopyranosyloxypyrazole derivatives represented by the general formula: wherein one of Q and T represents a group represented by the general formula: while the other represents a lower alkyl group or a halo(lower alkyl) group; Rrepresents a hydrogen atom, an optionally substituted lower alkyl group, a lower alkenyl group, a cyclic lower alkyl group, etc.; Rrepresents a hydrogen atom, an optionally substituted lower alkyl group, a lower alkoxy group, a lower alkenyl group, a cyclic lower alkyl group, a cyclic lower alkoxy group, etc., which exert an excellent inhibitory activity in human SGLT2, and therefore are useful as drugs for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, diabetic complications or obesity, pharmaceutically acceptable salts thereof or prodrugs thereof, production intermediates thereof and pharmaceutical uses thereof.